The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic

The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic

Background and aim: While the link between antipsychotic treatment and metabolic adverse events, including type 2 diabetes mellitus (T2DM) are clear in adults with schizophrenia, in young this association is not so well studied although the use of secondgeneration antipsychotics (SGA) is more and mo...

Full description

Bibliographic Details
Main Authors: Cason Nicolae-Marius, Babeș Petru Aurel, Béres Enikő, Babeș Katalin
Format: Article
Language:English
Published: Sciendo 2019-12-01
Series:Romanian Journal of Diabetes Nutrition and Metabolic Diseases
Subjects:
schizophrenia
young adult
second-generation antipsychotic agents
metabolic side effects of drugs and substances
diabetes mellitus type 2
olanzapine
Online Access:https://doi.org/10.2478/rjdnmd-2019-0047
id doaj-5b808fbaedf244c88f9675cd48105082
record_format Article
spelling doaj-5b808fbaedf244c88f9675cd481050822021-09-05T14:01:25ZengSciendoRomanian Journal of Diabetes Nutrition and Metabolic Diseases2284-64172019-12-0126444545310.2478/rjdnmd-2019-0047rjdnmd-2019-0047The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical AntipsychoticCason Nicolae-Marius0Babeș Petru Aurel1Béres Enikő2Babeș Katalin3Kliniken St Lukas, Bad Griesbach im Rottal, GermanyFaculty of Medicine and Pharmacology, University of Oradea, Oradea, RomaniaEmergency Department, County Clinical Emergency Hospital, Oradea, RomaniaFaculty of Medicine and Pharmacology, University of Oradea, Oradea, RomaniaBackground and aim: While the link between antipsychotic treatment and metabolic adverse events, including type 2 diabetes mellitus (T2DM) are clear in adults with schizophrenia, in young this association is not so well studied although the use of secondgeneration antipsychotics (SGA) is more and more frequent.https://doi.org/10.2478/rjdnmd-2019-0047schizophreniayoung adultsecond-generation antipsychotic agentsmetabolic side effects of drugs and substancesdiabetes mellitus type 2olanzapine
collection DOAJ
language English
format Article
sources DOAJ
author Cason Nicolae-Marius
Babeș Petru Aurel
Béres Enikő
Babeș Katalin
spellingShingle Cason Nicolae-Marius
Babeș Petru Aurel
Béres Enikő
Babeș Katalin
The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic
Romanian Journal of Diabetes Nutrition and Metabolic Diseases
schizophrenia
young adult
second-generation antipsychotic agents
metabolic side effects of drugs and substances
diabetes mellitus type 2
olanzapine
author_facet Cason Nicolae-Marius
Babeș Petru Aurel
Béres Enikő
Babeș Katalin
author_sort Cason Nicolae-Marius
title The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic
title_short The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic
title_full The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic
title_fullStr The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic
title_full_unstemmed The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic
title_sort relative risk of developing type 2 diabetes mellitus in young adults with schizophrenia treated with different atypical antipsychotic
publisher Sciendo
series Romanian Journal of Diabetes Nutrition and Metabolic Diseases
issn 2284-6417
publishDate 2019-12-01
description Background and aim: While the link between antipsychotic treatment and metabolic adverse events, including type 2 diabetes mellitus (T2DM) are clear in adults with schizophrenia, in young this association is not so well studied although the use of secondgeneration antipsychotics (SGA) is more and more frequent.
topic schizophrenia
young adult
second-generation antipsychotic agents
metabolic side effects of drugs and substances
diabetes mellitus type 2
olanzapine
url https://doi.org/10.2478/rjdnmd-2019-0047
work_keys_str_mv AT casonnicolaemarius therelativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
AT babespetruaurel therelativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
AT bereseniko therelativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
AT babeskatalin therelativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
AT casonnicolaemarius relativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
AT babespetruaurel relativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
AT bereseniko relativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
AT babeskatalin relativeriskofdevelopingtype2diabetesmellitusinyoungadultswithschizophreniatreatedwithdifferentatypicalantipsychotic
_version_ 1717810238068883456

Similar Items